Amylyx Pharmaceuticals Inc (AMLX) — Cash Flow Reinvestment Rate
Amylyx Pharmaceuticals Inc (AMLX) has a Cash Flow Reinvestment Rate of 1.57x as of December 2023, reinvesting $21.28 Million (capex $356.00K plus investments $20.93 Million) from operating cash flow of $13.55 Million. Explore AMLX capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Amylyx Pharmaceuticals Inc Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for Amylyx Pharmaceuticals Inc across 1 annual periods. Also explore Amylyx Pharmaceuticals Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Amylyx Pharmaceuticals Inc (2023–2023)
Year-by-year capital reinvestment analysis for Amylyx Pharmaceuticals Inc. For live market cap and broader valuation context, see Amylyx Pharmaceuticals Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 13.28x | $158.29 Million | $11.92 Million | $1.24 Million | — |